1. AB1260 Baseline characteristics and patient satisfaction data from coach@home: the german support program for patients with rheumatic diseases treated with certolizumab pegol. (12th June 2018) Authors: Böhme, N.; Holst, A.-D.; Dybowski, F.; Volberg, C.; Pott, H.-G.; Lendl, U. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 1725 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. FRI0202 Safe and Effective Tocilizumab Therapy in Elderly Patients with Rheumatoid Arthritis. (15th July 2016) Authors: Specker, C.; Kaufmann, J.; Kellner, H.; Kästner, P.; Volberg, C.; Braunewell, V.; Aringer, A.; Sieburg, M.; Meier, L.; Hofmann, M.W.; Flacke, J.-P.; Tony, H.-P.; Fliedner, G. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 504 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. FRI0302 Tocilizumab, DMARDS and Glucocorticoids in Rheumatoid Arthritis – Interim Analysis of the German Non-Interventional Study Ichiban. (10th June 2014) Authors: Specker, C.; Kaufmann, J.; Vollmer, M.A.; Kellner, H.; Höhle, M.; Kühne, C.; Volberg, C.; Henes, J.C.; Zinke, S.; Moosig, F.; Bohl-Bühler, M.; Sieburg, M.; Aringer, M.; Hofmann, M.W.; Hellmann, P.; Fliedner, G. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 494 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. SAT0416 Interreader-reliability of standardized evaluation of ICG-enhanced fluorescence-optical imaging. (23rd January 2014) Authors: Werner, S.G.; Käßer, U.; Amberger, C.; Piesga, M.; Spiecker, F.; Volberg, C.; Schwenke, C.; Langer, H.-E.; Backhaus, M. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 613 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗